New Systemic Treatment Options for Hepatobiliary Cancers
In recent years, multiple treatment options were added for the first-line treatment of hepatocellular carcinoma as well as for first- and subsequent-line treatment of biliary tract cancers. As molecular profiling can help identify eligibility for more targeted clinical trials or therapies, physicians should consider gene testing. Knowledge of the new therapies will help better inform clinical decision-making.
Navigating a New Therapeutic Era for HCC: Expert Review of New Agents and Guideline Recommendations

The goal of this activity is to improve participants’ competence in applying the latest treatment approaches and interdisciplinary collaborative strategies towards optimal care of patients with hepatocellular carcinoma.

Collaborative Strategies to Ensure Optimal Application of the Latest Treatment Approaches in Hepatocellular Carcinoma

The goal of this activity is to improve participants’ competence in applying the latest treatment approaches and interdisciplinary collaborative strategies towards optimal care of patients with hepatocellular carcinoma.

Collaborative Strategies to Ensure Optimal Application of the Latest Treatment Approaches in Hepatocellular Carcinoma

The goal of this activity is to improve participants’ competence in applying the latest treatment approaches and interdisciplinary collaborative strategies towards optimal care of patients with hepatocellular carcinoma.

NCCN Guidelines® Insights - Hepatobiliary Cancers, Version 2.2019

The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts.

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Hepatocellular Carcinoma

Management of Advanced Hepatocellular Carcinoma

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Hepatocellular Carcinoma

Management of Advanced Hepatocellular Carcinoma

Updates on Screening and Diagnosis of Hepatocellular Carcinoma

This information was originally presented at the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care held in Orlando, Florida, from March 22 - 24, 2018.

Emerging Systemic Therapy Options in Advanced Hepatocellular Carcinoma

The goal of this program is to ensure that members of multidisciplinary teams, including physicians, nurses, pharmacists and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with h

Emerging Systemic Therapy Options in Advanced Hepatocellular Carcinoma

The goal of this program is to ensure that members of multidisciplinary teams, including physicians, nurses, pharmacists and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with h

Pages

Subscribe to RSS - Hepatocellular Carcinoma